Core Points - The China Drug Price Registration System officially launched on December 2, 2025, allowing domestic and foreign pharmaceutical companies to independently declare and register drug prices [3] - The system is designed to be independent of provincial medical procurement platforms, providing authoritative, standardized, and transparent market price registration and inquiry services [3] - This initiative is expected to facilitate the internationalization of Chinese innovative drugs, attract high-quality foreign new drugs into the Chinese market, and contribute to the establishment of a global pricing system, promoting the development of the global market for innovative drugs [3]

Core Viewpoint - The launch of China's drug price registration system on December 2, 2025, aims to provide a transparent and authoritative platform for domestic and international pharmaceutical companies to register drug prices independently [1] Group 1: System Overview - The drug price registration system is independent of provincial medical procurement platforms, ensuring a standardized and transparent service for market price registration and inquiry [1] - This system is designed to facilitate the entry of innovative drugs into the Chinese market and support the globalization of drug pricing [1] Group 2: Market Impact - The new system is expected to enhance the ability of Chinese innovative drugs to enter international markets, thereby promoting the global market development of innovative pharmaceuticals [1] - It will also attract more high-quality foreign new drugs to the Chinese market, contributing to a more competitive pharmaceutical landscape [1]